Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Pharma finds a way to gain weight
EP Vantage
Thu, 07/13/23 - 09:49 am
Tags:
obesity, Eli Lilly, Novo Nordisk, Wegovy, Mounjaro
Biopharma’s green shoots thriving in summer sun as deal activity returns
Fierce Biotech
Tue, 07/11/23 - 11:18 pm
Tags:
M&A, Eli Lilly, Siglion Therapeutics, DiCE Therapeutics, GSK, Bellus Health
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
Tags:
M&A, Amgen, Astellas, Eli Lilly, GSK, Horizon Therapeutics, Merck, Novartis, Pfizer, Seagen
Pfizer Just Canned One of Its Ozempic Killers. What's Next?
Motley Fool
Mon, 07/3/23 - 10:37 am
Tags:
Pfizer, obesity, lotiglipron, danuglipron, Novo Nordisk, Eli Lilly, Ozempic, Mounjaro
Lilly to Buy European ADC Player Emergence Therapeutics
BioSpace
Fri, 06/30/23 - 10:20 am
Tags:
Eli Lilly, M&A, Emergence Therapeutics, antibody-drug conjugate, oncology
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
Yahoo/Reuters
Thu, 06/29/23 - 11:56 am
Tags:
Eli Lilly, M&A, Sigilon, cell therapy, diabetes
ADA 2023 – Lilly unveils its triple threat
EP Vantage
Wed, 06/28/23 - 09:57 am
Tags:
Eli Lilly, Novo Nordisk, retatrutide, Wegovy, Mounjaro, obesity, clinical trials
Lilly forks over $2.4M to settle federal agency's age discrimination lawsuit
Fierce Pharma
Tue, 06/27/23 - 10:39 pm
Tags:
Eli Lilly, age discrimination, legal
Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle
Fierce Biotech
Mon, 06/26/23 - 10:00 am
Tags:
Eli Lilly, obesity, orforglipron, Pfizer, Novo Nordisk, Mounjaro
Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event?
Motley Fool
Wed, 06/21/23 - 11:02 pm
Tags:
Eli Lilly, DiCE Therapeutics, M&A
ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer
EP Vantage
Wed, 06/21/23 - 10:38 am
Tags:
ADA, Eli Lilly, Pfizer, diabetes, obesity, orforglipron, danuglipron, lotiglipron
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
Benzinga
Tue, 06/20/23 - 09:46 pm
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, Synjardy, type 2 diabetes, pediatric, FDA
Lilly makes fresh bet on IL-17 with $2.4B acquisition of Dice Therapeutics
Fierce Biotech
Tue, 06/20/23 - 11:31 am
Tags:
Eli Lilly, M&A, DiCE Therapeutics, autoimmune disease
Lilly’s Migraine Drug Emgality Fails to Outperform Pfizer’s Nurtec
BioSpace
Mon, 06/19/23 - 10:31 am
Tags:
Eli Lilly, Emgality, Pfizer, Nurtec, migraines
Eli Lilly's Mounjaro is primed to surpass Novo Nordisk's popular diabetes and obesity duo: report
Fierce Pharma
Mon, 06/19/23 - 10:29 am
Tags:
Eli Lilly, Novo Nordisk, Mounjaro, semaglutide, diabetes, obesity
Eli Lilly CEO says Medicare price negotiations could harm drug development
CNBC
Thu, 06/15/23 - 10:11 am
Tags:
Inflation Reduction Act, Eli Lilly, Medicare, David Ricks, Pharma CEOs, drug pricing
Eli Lilly’s Mounjaro likely to become ‘leading therapy’ for obesity and type 2 diabetes
Biopharma Reporter
Thu, 06/15/23 - 10:06 am
Tags:
Eli Lilly, Mounjaro, obesity, type 2 diabetes
Verve partners with Lilly on gene editing therapy for heart disease
BioPharma Dive
Thu, 06/15/23 - 10:02 am
Tags:
Eli Lilly, Verve Therapeutics, heart disease, gene editing
BIO: Can GLP-1s help you quit smoking or drinking? Lilly is looking into it—cautiously
Fierce Biotech
Fri, 06/9/23 - 11:47 am
Tags:
BIO 2023, Eli Lilly, GLP-1 agonist, smoking cessation, alcohol-use disorder
Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug
BioSpace
Thu, 06/8/23 - 09:56 am
Tags:
Eli Lilly, Takeda, legal, Actos, bladder cancer, diabetes, racketeering

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.